Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer

The present study is the first phase II clinical trial aimed to evaluate the efficacy and safety of S‐1 plus nanoparticle albumin‐bound paclitaxel (Nab‐PTX) as first‐line chemotherapy for advanced gastric cancer (AGC). Previously untreated patients with metastatic gastric adenocarcinoma received S‐1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: He, Ming‐ming, Wang, Feng, Jin, Ying, Yuan, Shu‐qiang, Ren, Chao, Luo, Hui‐yan, Wang, Zhi‐qiang, Qiu, Miao‐zhen, Wang, Zi‐xian, Zeng, Zhao‐lei, Li, Yu‐hong, Wang, Feng‐hua, Zhang, Dong‐sheng, Xu, Rui‐hua
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6215885/
https://ncbi.nlm.nih.gov/pubmed/30281875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13813
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi